Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Alcidion Group Ltd

Healthcare AU ALC

0.105AUD
-0.005(4.55%)

Last update at 2025-06-27T06:10:00Z

Day Range

0.100.11
LowHigh

52 Week Range

0.050.12
LowHigh

Fundamentals

  • Previous Close 0.11
  • Market Cap147.72M
  • Volume339542
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.19200M
  • Revenue TTM35.64M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 30.55M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Income before tax -8.69900M -4.74000M -3.90800M -0.93400M -4.01816M
Minority interest - - - - -
Net income -8.41700M -3.61700M -4.41200M -2.24400M -3.07660M
Selling general administrative 28.27M 0.98M 1.10M 0.94M 0.90M
Selling and marketing expenses 0.93M 0.84M 0.58M 0.57M 0.56M
Gross profit 31.92M 1.25M 3.29M 3.52M 0.40M
Reconciled depreciation 4.10M 3.19M 2.26M 0.46M 0.25M
Ebit -8.59600M -4.61500M -3.84000M -0.93100M -4.01816M
Ebitda -4.49600M -1.42800M -1.58400M -0.47400M -3.77078M
Depreciation and amortization 4.10M 3.19M 2.26M 0.46M 0.25M
Non operating income net other - - - - -
Operating income -7.64600M -4.72600M -1.72800M -0.17400M -2.31801M
Other operating expenses 37.43M 45.13M 36.08M 26.06M 20.87M
Interest expense 0.10M 0.12M 0.07M 0.00300M 0.07M
Tax provision -0.28200M -1.12300M 0.50M 1.31M -0.94156M
Interest income 0.08M 0.11M 0.02M 0.01M 0.07M
Net interest income -0.02000M -0.01400M -0.04400M 0.00900M 0.07M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.28200M -1.12300M 0.50M 1.31M -0.94156M
Total revenue 37.06M 40.40M 34.35M 25.88M 18.55M
Total operating expenses 32.29M 5.98M 5.02M 3.69M 2.72M
Cost of revenue 5.14M 39.15M 31.06M 22.36M 18.15M
Total other income expense net -1.05300M -0.01400M -2.18000M -0.76000M -1.70015M
Discontinued operations - - - - -
Net income from continuing ops -8.41700M -3.61700M -4.41200M -2.24400M -3.07660M
Net income applicable to common shares - -3.61700M -4.41200M -2.24400M -3.07660M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 114.46M 120.68M 128.35M 58.38M 39.43M
Intangible assets - 29.07M 31.06M 2.03M 2.03M
Earning assets - - - - -
Other current assets 1.53M 1.60M 1.67M 1.21M 0.44M
Total liab 27.52M 30.52M 34.40M 13.16M 9.70M
Total stockholder equity 86.94M 90.17M 93.95M 45.22M 29.74M
Deferred long term liab - - - - -
Other current liab 5.38M 6.84M 9.22M 4.96M 3.51M
Common stock 115.52M 110.51M 110.51M 58.57M 41.07M
Capital stock - 110.51M 110.51M 58.57M 41.07M
Retained earnings -30.02000M -21.60300M -17.98600M -13.57400M -11.32975M
Other liab - 7.78M 8.14M 0.15M 0.15M
Good will 67.76M 67.76M 67.76M 25.46M 15.37M
Other assets 0.00000M - - 0.00000M 1.26M
Cash 11.80M 14.64M 17.34M 25.03M 15.95M
Cash and equivalents - - - - -
Total current liabilities 19.21M 21.27M 24.39M 13.00M 9.41M
Current deferred revenue 12.83M 11.61M 12.91M 7.11M 4.73M
Net debt -10.10300M -12.48600M -14.85500M -24.84600M -15.63211M
Short term debt 0.70M 0.69M 0.62M 0.16M 0.18M
Short long term debt - - - - -
Short long term debt total 1.70M 2.15M 2.48M 0.18M 0.32M
Other stockholder equity - 0.32M 1.43M 0.23M 0.62M
Property plant equipment - 2.87M 3.27M 0.55M 0.55M
Total current assets 18.54M 20.98M 26.26M 30.35M 20.23M
Long term investments - - - - -
Net tangible assets - -6.66800M -4.86900M 17.73M 12.34M
Short term investments - - - - -
Net receivables 5.21M 4.74M 7.25M 4.11M 3.83M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.30M 2.13M 1.65M 0.77M 0.99M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.45M 1.26M 1.43M 0.23M -0.61645M
Additional paid in capital - - - - -
Common stock total equity - - - - 41.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 26.19M - -0.00200M - -
Deferred long term asset charges - - - - -
Non current assets total 95.92M 99.71M 102.09M 28.04M 19.21M
Capital lease obligations - 2.15M 2.48M 0.18M 0.32M
Long term debt total - 1.46M 1.87M 0.02M 0.14M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -3.14100M -59.74300M -9.84300M -0.36204M -1.74081M
Change to liabilities -1.71200M 4.27M 2.92M -0.47829M 0.77M
Total cashflows from investing activities -3.14100M -59.74300M -9.84300M -0.36204M -1.74081M
Net borrowings -0.61600M -0.60900M -0.27000M -0.20683M 0.03M
Total cash from financing activities -0.61600M 51.33M 17.23M 15.16M 0.03M
Change to operating activities 0.54M -0.52800M -0.85500M 1.73M 3.13M
Net income -3.61700M -4.41200M -2.24400M -3.07660M -0.08417M
Change in cash -2.69800M -7.68800M 9.08M 12.78M 0.28M
Begin period cash flow 17.34M 25.03M 15.95M 3.17M 2.89M
End period cash flow 14.64M 17.34M 25.03M 15.95M 3.17M
Total cash from operating activities 0.17M -2.15600M 1.54M -2.01718M 1.99M
Issuance of capital stock - 51.94M 17.50M 15.36M -
Depreciation 1.81M 2.26M 0.46M 0.25M 0.07M
Other cashflows from investing activities -2.68700M -59.43200M -9.53000M -0.23822M -1.47603M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 2.52M -1.30200M 1.03M -0.41046M -1.89373M
Sale purchase of stock 0.00000M 51.94M 17.50M 15.36M -
Other cashflows from financing activities -0.61600M -0.60900M -0.27000M -0.17547M 0.09M
Change to netincome -0.36800M 0.33M 0.23M -0.00121M -0.00121M
Capital expenditures 0.45M 0.31M 0.31M 0.12M 0.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.11M 0.02M 0.01M 0.07M 0.02M
Stock based compensation - - - - -
Other non cash items - 2.16M 1.79M 2.83M 0.02M
Free cash flow -0.28500M -2.46700M 1.23M -0.12382M -0.26478M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALC
Alcidion Group Ltd		 -0.005 4.55% 0.10 - 109.89 4.15 1.73 3.97 53.70
PME
Pro Medicus Ltd		 2.85 1.03% 280.58 297.20 163.93 158.11 130.54 156.26 205.31
CGS
CogState Ltd		 0.005 0.29% 1.73 24.71 17.30 6.19 3.89 2.89 10.64
ONE
Oneview Healthcare PLC		 -0.015 5.56% 0.26 - - 21.96 9.17 10.99 -3.5247
SHG
Singular Health Group Ltd		 -0.015 4.11% 0.35 - - 115.45 21.41 15.13 -1.4686

Reports Covered

Stock Research & News

View All

Profile

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a fast healthcare interoperability resource (FHIR)-events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). Its platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; comprehensive health record for informed patient care; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; PCS PAS to manage patient-related administrative tasks; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Alcidion Group Ltd

9 Yarra Street, South Yarra, VIC, Australia, 3141

Key Executives

Name Title Year Born
Ms. Kate Quirke MD, CEO & Exec. Director NA
Mr. Matthew Gepp Chief Financial Officer NA
Mr. Colin Bruce MacKinnon Chief Operating Officer NA
Mr. Vivek Krishnan Chief Technology Officer NA
Kerstin Wahlqvist Investor Relations Mang. NA
Ms. Maria Hunter Group Gen. Counsel NA
Ms. Tracey Harvey HR Mang. NA
Ms. Lynette Ousby UK Managing Director NA
Ms. Amanda James Chief People Officer NA
Ms. Julia Stevens Chief of Staff NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.